The Polygenic and Monogenic Basis of Blood Traits and Diseases

Summary
Blood cells play essential roles in human health, underpinning physiological processes such as immunity, oxygen transport, and clotting, which when perturbed cause a significant health burden. Here we integrate data from UK Biobank and a large-scale international collaborative effort, including 563,946 European ancestry participants, and discover 5,106 new genetic variants independently associated with 29 blood cell phenotypes covering the full allele frequency spectrum of variation impacting hematopoiesis. We holistically characterize the genetic architecture of hematopoiesis, assess the relevance of the omnigenic model to blood cell phenotypes, delineate relevant hematopoietic cell states influenced by regulatory genetic variants and gene networks, identify novel splice-altering variants mediating the associations, and assess the polygenic prediction potential for blood cell traits and clinical disorders at the interface of complex and Mendelian genetics. These results show the power of large-scale blood cell GWAS to interrogate clinically meaningful variants across the full allelic spectrum of human variation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding details are provided in the supplementary information.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† A list of members and their affiliations appears in the Supplementary Information.
Data Availability
Summary statistics for GWAS results are available to download from ftp://ftp.sanger.ac.uk/
Subject Area
- Addiction Medicine (424)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3240)
- Dermatology (271)
- Emergency Medicine (476)
- Epidemiology (13263)
- Forensic Medicine (19)
- Gastroenterology (892)
- Genetic and Genomic Medicine (5075)
- Geriatric Medicine (471)
- Health Economics (776)
- Health Informatics (3202)
- Health Policy (1130)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (515)
- Neurology (4829)
- Nursing (256)
- Nutrition (717)
- Oncology (2490)
- Ophthalmology (709)
- Orthopedics (279)
- Otolaryngology (338)
- Pain Medicine (321)
- Palliative Medicine (89)
- Pathology (533)
- Pediatrics (1284)
- Primary Care Research (551)
- Public and Global Health (7397)
- Radiology and Imaging (1677)
- Respiratory Medicine (975)
- Rheumatology (474)
- Sports Medicine (417)
- Surgery (536)
- Toxicology (70)
- Transplantation (233)
- Urology (202)